Beneficient (BENFW) EBITDA (2021 - 2025)

Beneficient's EBITDA history runs 5 years deep, the most recent figure standing at $19.9 million for Q4 2025.

• In Q4 2025, EBITDA rose 327.34% year-over-year to $19.9 million; the TTM figure through Dec 2025 stood at -$49.6 million (down 381.04% YoY), while the FY2025 annual figure was $50.9 million, up 102.43% from the prior year.
• EBITDA came in at $19.9 million for Q4 2025 at Beneficient, up from -$3.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $47.6 million in Q2 2024 to a low of -$1.1 billion in Q2 2023.
• A 5-year average of -$154.0 million and a median of -$7.8 million in 2021 frame the typical range for EBITDA.
• Across the five-year window, EBITDA plunged 7103.41% in 2023 and jumped 327.34% in 2025, its largest moves.
• Beneficient's EBITDA stood at -$6.8 million in 2021, then rose by 24.04% to -$5.2 million in 2022, then sank by 10402.03% to -$542.1 million in 2023, then surged by 98.38% to -$8.8 million in 2024, then soared by 327.34% to $19.9 million in 2025.
• According to Business Quant data, EBITDA over the past three periods registered $19.9 million, -$3.5 million, and -$65.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison